Machine Learning

Semiconductor metrology leader Nova adds seasoned investor Rami Hadar to its board, signaling a strategic push to accelerate growth and innovation.

Core AI divests its cash-burning Siyata Mobile hardware unit just months after merging, betting its future entirely on AI-powered gaming and content.

A Korean AI startup raised $854K for a gesture-control ring, betting its enterprise-grade tech can unlock the future of post-touch computing.

Early data shows QurAlis' QRL-101 successfully engaged its intended target in ALS patients, a key step for a novel drug aimed at quelling neuronal storm.

Valens Semiconductor's 2024 ESG report details major drops in emissions and energy use, but how do these gains stack up in the high-stakes tech world?

Bluejay Diagnostics can now make 9 million sepsis tests. This manufacturing win is huge, but the real race for FDA approval has only just begun.

EUDA Health's new Helixé 2.0 supplement boasts enhanced potency, nano-delivery tech, and Halal certification to capture the booming global wellness market.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

Samsung's 2026 AI TVs will be the first to feature a native Google Photos app, using exclusive AI tools to turn your memories into a cinematic experience.

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

As pharma moves beyond small molecules, a new integrated platform helps developers navigate the challenges of PROTACs, peptides, and antibody drugs.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

With just days until Christmas, CINCOM unveils discounted wellness bundles. The move tests the market's appetite for last-minute practical gifts.

A new cell-free therapy for the fatal lung disease IPF is heading to clinical trials, thanks to a key manufacturing partnership. Here's what it means.

Ursa Space Systems has been selected for the MDA's $151B SHIELD contract, signaling a new era of AI-driven satellite intelligence for homeland defense.

Swisslog Healthcare appoints Maria Garces from competitor Omnicell as VP, signaling an aggressive push to innovate and dominate the health tech market.

Mirum raises over a quarter-billion dollars to acquire Bluejay Therapeutics, targeting a high-potential liver disease drug and signaling major growth.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.